Hantz Financial Services, Inc. Pacira Bio Sciences, Inc. Transaction History
Hantz Financial Services, Inc.
- $6.6 Billion
- Q3 2025
A detailed history of Hantz Financial Services, Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 1,132 shares of PCRX stock, worth $26,918. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,132
Previous 411
175.43%
Holding current value
$26,918
Previous $10,000
190.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PCRX
# of Institutions
261Shares Held
49.1MCall Options Held
118KPut Options Held
63.7K-
Black Rock Inc. New York, NY8.01MShares$190 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.2MShares$124 Million0.0% of portfolio
-
Doma Perpetual Capital Management LLC Miami, FL2.7MShares$64.2 Million23.38% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.16MShares$51.4 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.14MShares$50.8 Million0.08% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.09B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...